Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
We surveyed the serotypes and antimicrobial susceptibility profile of 176 S. pneumoniae isolates obtained from the middle ear fluid of Japanese children with AOM between April and September 2013, aim to evaluate the impact of seven-valent pneumococcal conjugate vaccine (PCV7). Serotype 19A, 15A and 3 showed a high frequency and we revealed the serotype replacement of PCV7. Serotype 15A is not included in second-generation vaccine (13-valent pneumococcal conjugate vaccine), and all isolates of serotype 15A in this study showed multi-drug resistance. Furthermore, by multilocus sequence typing, we revealed all serotype 15A isolates exept one was included in clonal complex 63 and was genetically close.
|